Axsome's drug for Alzheimer's disease agitation meets main goal in late-stage study
ReutersDec 30, 2024 12:09 PM
Dec 30 (Reuters) - Axsome Therapeutics AXSM.O said on Monday its experimental treatment for the Alzheimer's disease-related agitation met the main goal of a late-stage trial.
(Reporting by Sneha S K; Editing by Shilpi Majumdar)
((Sneha.SK@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
The Ultimate AI Investment Guide:Opportunities, Risks, and Strategies for the Next Generation of Technology Markets
TradingKey - OpenAI’s recent multi-billion-dollar partnerships—with Nvidia, AMD, and Broadcom—have flooded headlines and lifted markets, but they’ve also sparked a new round of debate: Is Sam Altman steering us toward a runaway tech bubbleTradingKey
6 hours ago
TSMC Q3 Earnings Preview: Record Revenue Is a Lock, but an Upgraded Outlook Could Be the Real Catalyst
TradingKey - Global semiconductor foundry leader Taiwan Semiconductor Manufacturing Company (TSMC, TSM) will report its Q3 2025 earnings on Thursday, October 16, before U.S. markets open. With record-breaking revenue already confirmed by monthly reports, analysts expect record profits andTradingKey
10 hours ago
What Is the Debasement Trade? Markets Have Picked Three Winners and One Loser
TradingKey - Since October, as the U.S. dollar, yen, and euro weaken, while gold, silver, and Bitcoin surge to new highs, Wall Street has embraced a powerful new investment narrative: the “Debasement Trade.” This term captures the extraordinary shift of capital from traditional currencies andTradingKey
12 hours ago
UK August GDP: Economy & Assets—Set to Collapse?
TradingKey - The UK is scheduled to release its August GDP figures on 16 October, with the market widely anticipating a 0.1% month-on-month increase in real GDP (Figure 1). If this expectation is fulfilled, it will represent the UK economy’s third consecutive month of recovery, following two straighTradingKey
Mon, Oct 13
U.S. Banks Q3 Earnings Preview: Big 5 Banks See Double-Digit EPS Growth, Investment Banking Hits 4-Year High
TradingKey - The 2025 U.S. earnings season kicks off this week with results from major banks. Amid elevated investor sentiment and the Trump administration pushing for deregulation, analysts expect another strong quarter for the banking sector — driven by booming trading activity and a resurgenceTradingKey
Mon, Oct 13
